Published: BOPA Guide to Producing a Position Statement

As an organisation BOPA represents the interests of its members and the wider oncology pharmacy workforce by developing and adopting position statements in response to changes in healthcare policy, or to address areas of unmet need identified by BOPA members.

The BOPA Governance, Advocacy and Publication (GAP) committee, working alongside the BOPA executive committee, is responsible for reviewing and endorsing position statements. To ensure that BOPA best represents the interests of its members, the GAP committee encourages members to produce and submit draft position statements for consideration. To aid this process, the GAP committee has produced the following guidance.

BOPA Guide to Producing a Position Statement – BOPA

Latest News

By NHS Infusions and Special Medicines Programme on 4th September 2026

Expressions of interest for Expert Panel Sub Group to support the approval and implementation of Standardised Product Specifications

Expressions of interest for Expert Panel Sub Group to support the approval and implementation of Standardised Product Specifications The Infusions and Special Medicines Programme is inviting expressions of interest for…

Read article
By BOPA on 31st August 2026

🌟 BOPA Advanced Pharmacist Study Day – Elevate Your Practice, Shape Your Career

Are you an oncology or haematology pharmacist with around five or more years of experience — whether Band 7 or Band 8 — and ready to take the next step…

Read article
By BOPA Executive Committee on 31st August 2026

BOPA 2026 Executive Committee Election – One week left to cast your vote

One week left to cast your vote for the BOPA Executive Committee Election. Have your say at BOPA’s future.   In 2026 we received 9 nominations for 6 positions. -Standard…

Read article
By BOPA Executive Committee on 27th August 2026

UK multidisciplinary Consensus Document – Safe Management of Hazardous Medicinal Products in UK Healthcare Settings

We are pleased to jointly publish the new UK multidisciplinary consensus document, Safe Management of Hazardous Medicinal Products in UK Healthcare Settings. Hazardous medicinal products (HMPs) are used across a…

Read article